United Capital Financial Advisers, LLC Regeneron Pharmaceuticals, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.7 Billion
  • Q4 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 2,370 shares of REGN stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,370
Previous 3,001 21.03%
Holding current value
$1.67 Million
Previous $3.15 Million 46.48%
% of portfolio
0.01%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$701.85 - $1046.91 $442,867 - $660,600
-631 Reduced 21.03%
2,370 $1.69 Million
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $26,626 - $31,245
-26 Reduced 0.86%
3,001 $3.15 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $28,262 - $34,278
32 Added 1.07%
3,027 $3.18 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $303,303 - $333,765
-336 Reduced 10.09%
2,995 $2.88 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $857,349 - $975,160
-1,106 Reduced 24.93%
3,331 $2.93 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $160,648 - $195,893
-232 Reduced 4.97%
4,437 $3.65 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $51,802 - $61,445
74 Added 1.61%
4,669 $3.35 Million
Q1 2023

Aug 14, 2023
SELL
$680.49 - $826.97 $50,356 - $61,195
-74 Reduced 1.58%
4,595 $3.78 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $584,540 - $710,367
859 Added 22.99%
4,595 $3.78 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $1.54 Million - $1.67 Million
2,176 Added 139.49%
3,736 $2.7 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $29,846 - $37,664
52 Added 3.45%
1,560 $1.07 Million
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $26,869 - $36,203
-49 Reduced 3.15%
1,508 $891,000
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $42,848 - $50,286
-72 Reduced 4.42%
1,557 $1.09 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $46,739 - $57,703
-86 Reduced 5.01%
1,629 $1.03 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $123,990 - $147,087
-216 Reduced 11.19%
1,715 $1.04 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $181,082 - $213,920
-383 Reduced 16.55%
1,931 $1.08 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $25,910 - $31,795
-58 Reduced 2.45%
2,314 $1.1 Million
Q4 2020

Feb 17, 2021
BUY
$478.3 - $607.98 $134,402 - $170,842
281 Added 13.44%
2,372 $1.15 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $33,774 - $40,809
62 Added 3.06%
2,091 $1.17 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $408,962 - $533,809
829 Added 69.08%
2,029 $1.27 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $105,560 - $155,251
314 Added 35.44%
1,200 $586,000
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $143,095 - $196,538
522 Added 143.41%
886 $332,000
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $161,067 - $187,531
-589 Reduced 61.8%
364 $101,000
Q2 2019

Aug 13, 2019
BUY
$299.6 - $414.82 $91,078 - $126,105
304 Added 46.84%
953 $298,000
Q1 2019

May 14, 2019
SELL
$372.08 - $439.57 $257,107 - $303,742
-691 Reduced 51.57%
649 $266,000
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $21,156 - $25,391
63 Added 4.93%
1,340 $500,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $236,668 - $275,335
674 Added 111.77%
1,277 $516,000
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $22,768 - $27,599
-80 Reduced 11.71%
603 $208,000
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $38,845 - $48,434
123 Added 21.96%
683 $235,000
Q4 2017

Feb 13, 2018
SELL
$358.63 - $469.95 $10,041 - $13,158
-28 Reduced 4.76%
560 $214,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $46,157 - $53,928
107 Added 22.25%
588 $263,000
Q2 2017

Aug 14, 2017
BUY
N/A
481
481 $236,000

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email